Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Yasuyuki Goto's publication output changed over time?
ScholarIQpublication output · 1995–2024
Output grew0% over the shown period — from 1 works in 1995 to 1 in 2024.
1
1
1
1
1
3
1
1
1
199520052006200720082009201120122024
What are the most-cited papers on Yasuyuki Goto?
ScholarIQmost cited works
Sex Hormones, Hormonal Interventions, and Gastric Cancer Risk: A Meta-analysis
M. Constanza Camargo, Yasuyuki Goto, Jovanny Zabaleta, Douglas R. Morgan, Pelayo Correa, Charles S. Rabkin
S8391440. 2012291 CitationsOPEN ACCESS
Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells
Rhea N. Coler, Yasuyuki Goto, Lisa Bogatzki, Vanitha S. Raman, Steven G. Reed
S128227336. 2007201 CitationsOPEN ACCESS
Optimized subunit vaccine protects against experimental leishmaniasis
Sylvie Bertholet, Yasuyuki Goto, Lauren Carter, Ajay Bhatia, Randall F. Howard, Darrick Carter, Rhea N. Coler, Thomas S. Vedvick, Steven G. Reed
Vaccine. 2009104 Citations
Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
Susan L. Baldwin, Narek Shaverdian, Yasuyuki Goto, Malcolm S. Duthie, Vanitha S. Raman, Tara Evers, Farah Mompoint, Thomas S. Vedvick, Sylvie Bertholet, Rhea N. Coler, Steven G. Reed
Vaccine. 200999 Citations
Genetic factors involved in the development of <i>Helicobacter pylori</i>‐related gastric cancer
Nobuyuki Hamajima, Mariko Naito, Takaaki Kondo, Yasuyuki Goto
S175946340. 200693 CitationsOPEN ACCESS
Related on ScholarIQ
The University of Tokyo
Institution
Sex Hormones, Hormonal Interventions, and Gastric Cancer Risk: A Meta-analysis
Paper
Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells
Paper
Optimized subunit vaccine protects against experimental leishmaniasis
Paper
Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
Paper
Genetic factors involved in the development of <i>Helicobacter pylori</i>‐related gastric cancer
Paper